These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22032306)

  • 1. Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.
    Hopfner F; Schormair B; Knauf F; Berthele A; Tölle TR; Baron R; Maier C; Treede RD; Binder A; Sommer C; Maihöfner C; Kunz W; Zimprich F; Heemann U; Pfeufer A; Näbauer M; Kääb S; Nowak B; Gieger C; Lichtner P; Trenkwalder C; Oexle K; Winkelmann J
    BMC Neurol; 2011 Oct; 11():134. PubMed ID: 22032306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome.
    Dibbens L; Schwake M; Saftig P; Rubboli G
    Epileptic Disord; 2016 Sep; 18(S2):63-72. PubMed ID: 27582254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
    Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
    Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
    Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
    Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity.
    Zeigler M; Meiner V; Newman JP; Steiner-Birmanns B; Bargal R; Sury V; Mengistu G; Kakhlon O; Leykin I; Argov Z; Abramsky O; Lossos A
    J Neurol Sci; 2014 Apr; 339(1-2):210-3. PubMed ID: 24485911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review.
    Atasu B; Acarlı ANO; Bilgic B; Baykan B; Demir E; Ozluk Y; Turkmen A; Hauser AK; Guven G; Hanagasi H; Gurvit H; Emre M; Gasser T; Lohmann E
    BMC Neurol; 2022 Mar; 22(1):122. PubMed ID: 35346091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy.
    Dibbens LM; Karakis I; Bayly MA; Costello DJ; Cole AJ; Berkovic SF
    Arch Neurol; 2011 Jun; 68(6):812-3. PubMed ID: 21670406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Homozygous Splice-Site Mutation in
    He J; Lin H; Li JJ; Su HZ; Wang DN; Lin Y; Wang N; Chen WJ
    Chin Med J (Engl); 2018 Jul; 131(13):1575-1583. PubMed ID: 29941711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure.
    Yari A; Ali-Nejad RM; Saleh-Gohari N
    Neurol Sci; 2021 Dec; 42(12):5077-5085. PubMed ID: 33772352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.
    Dibbens LM; Michelucci R; Gambardella A; Andermann F; Rubboli G; Bayly MA; Joensuu T; Vears DF; Franceschetti S; Canafoglia L; Wallace R; Bassuk AG; Power DA; Tassinari CA; Andermann E; Lehesjoki AE; Berkovic SF
    Ann Neurol; 2009 Oct; 66(4):532-6. PubMed ID: 19847901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations.
    Fu YJ; Aida I; Tada M; Tada M; Toyoshima Y; Takeda S; Nakajima T; Naito H; Nishizawa M; Onodera O; Kakita A; Takahashi H
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):551-63. PubMed ID: 23659519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings.
    Chaves J; Beirão I; Balreira A; Gaspar P; Caiola D; Sá-Miranda MC; Lima JL
    Seizure; 2011 Nov; 20(9):738-40. PubMed ID: 21782476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis.
    Berkovic SF; Dibbens LM; Oshlack A; Silver JD; Katerelos M; Vears DF; Lüllmann-Rauch R; Blanz J; Zhang KW; Stankovich J; Kalnins RM; Dowling JP; Andermann E; Andermann F; Faldini E; D'Hooge R; Vadlamudi L; Macdonell RA; Hodgson BL; Bayly MA; Savige J; Mulley JC; Smyth GK; Power DA; Saftig P; Bahlo M
    Am J Hum Genet; 2008 Mar; 82(3):673-84. PubMed ID: 18308289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2.
    Perandones C; Micheli FE; Pellene LA; Bayly MA; Berkovic SF; Dibbens LM
    Mov Disord; 2012 Aug; 27(9):1200-1. PubMed ID: 22767442
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.
    Higashiyama Y; Doi H; Wakabayashi M; Tsurusaki Y; Miyake N; Saitsu H; Ohba C; Fukai R; Miyatake S; Joki H; Koyano S; Suzuki Y; Tanaka F; Kuroiwa Y; Matsumoto N
    Mov Disord; 2013 Apr; 28(4):552-3. PubMed ID: 23325613
    [No Abstract]   [Full Text] [Related]  

  • 16. A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure.
    Guerrero-López R; García-Ruiz PJ; Giráldez BG; Durán-Herrera C; Querol-Pascual MR; Ramírez-Moreno JM; Más S; Serratosa JM
    Mov Disord; 2012 Dec; 27(14):1826-7. PubMed ID: 23225201
    [No Abstract]   [Full Text] [Related]  

  • 17. A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure.
    Perandones C; Pellene LA; Micheli F
    Mov Disord; 2014 Jan; 29(1):158-9. PubMed ID: 24339182
    [No Abstract]   [Full Text] [Related]  

  • 18. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder.
    Badhwar A; Berkovic SF; Dowling JP; Gonzales M; Narayanan S; Brodtmann A; Berzen L; Caviness J; Trenkwalder C; Winkelmann J; Rivest J; Lambert M; Hernandez-Cossio O; Carpenter S; Andermann F; Andermann E
    Brain; 2004 Oct; 127(Pt 10):2173-82. PubMed ID: 15364701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
    Gonzalez A; Valeiras M; Sidransky E; Tayebi N
    Mol Genet Metab; 2014 Feb; 111(2):84-91. PubMed ID: 24389070
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.